Total amount of cytotoxic agents found on the exterior of the vial from wiping 10 vials
| Active drug | Active form in vial | Manufacturer involved | Amount of active ingredient in 10 vials (mg) | Amount of active ingredient on surfaces of 10 vials (ng) | |
| Batch 1 | Batch 2 | ||||
| Cyclophosphamide | Powder for injection | Endoxan 1 g (Baxter) | 10 000 | 30 ng >5 and <50 | 12 ng >5 and <50 |
| Cytarabine | Liquid | Cytarabine 2000 mg/20 mL with plastic overwrap (Accord Healthecare) | 20 000 | 250 ng >200 and <2000 | 100 ng >25 and <250 |
| Doxorubicin | Liquid | Doxorubicin 50 mg/25 mL with plastic overwrap (Teva Santé) | 500 | <10 ng | <10 ng |
| Etoposide phosphate | Powder for injection | Etopophos 100 mg (Bristol-Myers Squibb) | 1000 | <2 ng | <2 ng |
| Ifosfamide | Powder for injection | Holoxan 2000 mg/50 mL (Baxter) | 20 000 | 5 ng >0.5 and <10 | 150 ng >50 and <200 |
| Busulfan | Liquid | Busulfan 60 mg/10 mL with plastic overwrap (Fresenius) | 600 | <5 ng | <5 ng |